Showing results (121-130 of 388) with videos related to
Sort By:
Pageof 39
Expert Opinion on Therapeutic Patents|November 19, 2016
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2)Boshi Huang, Zhongxia Zhou, Dongwei Kang, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|June 30, 2012
Ligustrazine derivatives. Part 6: design, synthesis and evaluation of novel ligustrazinyl acylguanidine derivatives as potential cardiovascular agentsZhenyu Li, Fang Yu, Lei Cui, et al.Expert Opinion on Therapeutic Patents|February 22, 2025
A patent review of hepatitis B virus core protein allosteric modulators (2019-present)Shuo Wang, Feiyue Ma, Kai Tang, et al.European Journal of Medicinal Chemistry|August 14, 2020
Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitorsBin Sun, Yue Dong, Yunfei An, et al.Molecules (Basel, Switzerland)|July 14, 2023
Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB PathwayMeng Chen, Lianhua Lu, Dong Cheng, et al.Expert Opinion on Therapeutic Patents|February 8, 2018
Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014-2017)Xiaofang Zuo, Zhipeng Huo, Dongwei Kang, et al.Journal of Environmental Management|October 4, 2025
Spatiotemporal evolution characteristics, driving factors, and risk assessment of water quality in long-distance inter-basin water transfer projects during 2015-2023Qifan Zhang, Pengfei Wang, Weijun Sun, et al.Journal of Medicinal Chemistry|July 13, 2026
Research Progress and Challenges of Anti-monkeypox Virus Drugs Targeting F13 ProteinLe Wang, Tao Zhang, Jie Guo, et al.Bioorganic & Medicinal Chemistry|October 30, 2007
Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs)Yongqiang Lin, Xinyong Liu, Renzhang Yan, et al.Current Medicinal Chemistry|February 11, 2015
The Changing Face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5ADiwakar Rai, Liu Wang, Xuemei Jiang, et al.Pageof 39